Moreover, we found that FXR upregulates IL-6 and IL-6ST expression but not IL6Rɑ, thus suggesting that IL-6/IL-6ST may mediate FXR-modulated Jak2/STAT3 activation and tumor metastasis in NSCLC. This evidence concerns the gene JAK2 and non-small cell lung carcinoma.